Uses and compositions for treatment of psoriatic arthritis

  • US 9,624,295 B2
  • Filed: 04/10/2007
  • Issued: 04/18/2017
  • Est. Priority Date: 04/10/2006
  • Status: Active Grant
First Claim
Patent Images

1. A method of treating a subject having oligoarthritis with a tender joint count (TJC)<

  • 5 or a swollen joint count (SJC)<

    5, in association with psoriatic arthritis, the method comprising administering to the subject about 40 mg of adalimumab once subcutaneously every other week,wherein at least an ACR20 response is achieved following a treatment period of at least about 12 weeks and the at least an ACR20 response is maintained following a treatment period of at least about 48 weeks,thereby treating the subject having psoriatic arthritis with oligoarthritis in association with psoriatic arthritis.

View all claims
    ×
    ×

    Thank you for your feedback

    ×
    ×